WHO ICTRP trial

Comparison study of the pre emptive of the two dose of dexmedetomidine (bolus…

IRCT20101211005362N31 · Iranian Registry of Clinical Trials (IRCT) · Recruiting

Key facts

Trial ID IRCT20101211005362N31
Public title Comparison study of the pre emptive of the two dose of dexmedetomidine (bolus and infusion) on post operative pain, nausea and vomiting for laparoscopic cholecystectomy
Scientific title Comparison study of the preemptive of the two dose of dexmedetomidine (bolus and infusion) on post operative pain, nausea and vomiting for laparoscopic cholecystectomy
Primary sponsor Esfahan University of Medical Sciences
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Recruiting
Study type interventional
Phase 1-2
Countries Iran (Islamic Republic of)
Conditions Pain, nausea and vomiting.
Interventions Intervention 1: Intervention group: Intravenous dexmedetomidine at a dose of 1 microgram per kilogram of body weight is given as a bolus dose 20 minutes before induction of anesthesia and then 0.5 micrograms per kilogram of body weight for…
Registration date Nov 7, 2022
Target size 90
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations